Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF
August 4, 2003
- 70% of People Had Allergic Symptoms in Past Year: JMARI Survey
August 4, 2003
- Website News
August 4, 2003
- Ain Pharmaciez, Sogo Medical "Patterns of Success": Nomura Securities
August 4, 2003
- Financial Results in 1st Quarter
August 4, 2003
- Pharmacists 5th Most-trusted Professionals in Japan: Poll
August 4, 2003
- Industry Frustrated with Korosho's Proposal for Review of NHI Pricing Rule: Chuikyo
August 4, 2003
- OTC NEWS IN BRIEF
August 4, 2003
- ON THE MOVE
August 4, 2003
- MEDICAL DEVICE NEWS IN BRIEF
August 4, 2003
- Korosho Opposes Council's Regulatory Reform Recommendations
August 4, 2003
- DIAGNOSTIC NEWS IN BRIEF
August 4, 2003
- Disclosure of Medical Charts to Become Obligatory: HPB Director General
August 4, 2003
- WORLD NEWS IN BRIEF
August 4, 2003
- Kinki Regional Health Bureau Starts Collective Bargaining
August 4, 2003
- PRESS SEMINAR
August 4, 2003
- REGULATORY NEWS IN BRIEF
August 4, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
August 4, 2003
- Medical, Nursing Care Costs to Total \51.1 Trillion. in 2017: JMA
August 4, 2003
- Aiming at \5 Bil. in Sales for OTC Sleep Improver Drewel: Mr Kayoo of SSP
August 4, 2003
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…